奥普罗(Opaloid)

奥普罗(Opaloid)致力于通过视网膜图像分析为病人作出相关疾病的初期诊断,提醒患者及时 就医。视网膜图像拥有包括阿兹海默症在内的大量疾病的早期征兆。但图像处理花费医生大量 时间精力。看病难的问题导致许多病患无法早获诊断,耽误就医时间。我们用最前沿的“深度学习”科技,通过分析视网膜图像为病人提供简单快速的初期诊断。用户只需安装简易的手机摄像头插件,就可自拍视网膜图像。我们的平台通过图像分析,快速判断患病几率。我们目前 已经能以超越普通眼科医生的准确度为用户初期诊断包括青光眼和糖尿病视网膜病变之内的各类疾病。

 

Opaloid aims to bring retinal imaging based point-of-care diagnosis to primary care and patient’s home. Retinal health reflects many serious diseases, including early signs of Alzheimer’s. However, its accessibility has been hindered by its bulky imaging system and labor-intensive manual image assessment. Opaloid breaks this barrier. With a low-cost smartphone adaptor and easy instructions, Opaloid enables anyone to take retinal images. Then, using most advanced deep learning driven machine vision technologies, Opaloid automates the image assessment process and helps patients screen for serious diseases at early stage. Starting with glaucoma and diabetic retinopathy, world’s leading causes of blindness, Opaloid envisions affordable and accessible retinal health assessment for all.